Cargando…

Quantifying infective endocarditis risk in patients with predisposing cardiac conditions

AIMS: There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. METHODS AND RESULTS: English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quan...

Descripción completa

Detalles Bibliográficos
Autores principales: Thornhill, Martin H, Jones, Simon, Prendergast, Bernard, Baddour, Larry M, Chambers, John B, Lockhart, Peter B, Dayer, Mark J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927904/
https://www.ncbi.nlm.nih.gov/pubmed/29161405
http://dx.doi.org/10.1093/eurheartj/ehx655
_version_ 1783482363242610688
author Thornhill, Martin H
Jones, Simon
Prendergast, Bernard
Baddour, Larry M
Chambers, John B
Lockhart, Peter B
Dayer, Mark J
author_facet Thornhill, Martin H
Jones, Simon
Prendergast, Bernard
Baddour, Larry M
Chambers, John B
Lockhart, Peter B
Dayer, Mark J
author_sort Thornhill, Martin H
collection PubMed
description AIMS: There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. METHODS AND RESULTS: English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered ‘moderate risk’) had similar levels of risk (OR 66 and 57) and risks in other ‘moderate-risk’ conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered ‘high risk’ for 6 months following surgery) had lower risk than all ‘moderate-risk’ conditions—even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. CONCLUSION: These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some ‘moderate-risk’ patients was similar to that of several ‘high-risk’ conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation.
format Online
Article
Text
id pubmed-6927904
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-69279042019-12-30 Quantifying infective endocarditis risk in patients with predisposing cardiac conditions Thornhill, Martin H Jones, Simon Prendergast, Bernard Baddour, Larry M Chambers, John B Lockhart, Peter B Dayer, Mark J Eur Heart J Clinical Research AIMS: There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. METHODS AND RESULTS: English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered ‘moderate risk’) had similar levels of risk (OR 66 and 57) and risks in other ‘moderate-risk’ conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered ‘high risk’ for 6 months following surgery) had lower risk than all ‘moderate-risk’ conditions—even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. CONCLUSION: These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some ‘moderate-risk’ patients was similar to that of several ‘high-risk’ conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation. Oxford University Press 2018-02-14 2017-11-17 /pmc/articles/PMC6927904/ /pubmed/29161405 http://dx.doi.org/10.1093/eurheartj/ehx655 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Research
Thornhill, Martin H
Jones, Simon
Prendergast, Bernard
Baddour, Larry M
Chambers, John B
Lockhart, Peter B
Dayer, Mark J
Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title_full Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title_fullStr Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title_full_unstemmed Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title_short Quantifying infective endocarditis risk in patients with predisposing cardiac conditions
title_sort quantifying infective endocarditis risk in patients with predisposing cardiac conditions
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927904/
https://www.ncbi.nlm.nih.gov/pubmed/29161405
http://dx.doi.org/10.1093/eurheartj/ehx655
work_keys_str_mv AT thornhillmartinh quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT jonessimon quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT prendergastbernard quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT baddourlarrym quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT chambersjohnb quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT lockhartpeterb quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions
AT dayermarkj quantifyinginfectiveendocarditisriskinpatientswithpredisposingcardiacconditions